Literature DB >> 989658

Insulin secretion during oral treatment with beta-adrenergic blocking agents in diabetics.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 989658     DOI: 10.1007/bf02591584

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


× No keyword cloud information.
  8 in total

1.  Insulin response to intravenous glucose during long-term treatment with propranolol.

Authors:  H Hedstrand; H Aberg
Journal:  Acta Med Scand       Date:  1974 Jul-Aug

2.  Role of adrenergic receptors in glucose-induced insulin secretion in man.

Authors:  E Cerasi; S Effendic; R Luft
Journal:  Lancet       Date:  1969-08-09       Impact factor: 79.321

3.  Adrenergic modulation of basal insulin secretion in man.

Authors:  R P Robertson; D Porte
Journal:  Diabetes       Date:  1973-01       Impact factor: 9.461

4.  Depressed tolbutamide-induced insulin response in subjects treated with propranolol.

Authors:  F Massara; E Strumia; F Camanni; G M Molinatti
Journal:  Diabetologia       Date:  1971-08       Impact factor: 10.122

5.  Effects of propranolol on blood sugar, insulin and free fatty acids.

Authors:  S P Allison; M J Chamberlain; J E Miller; R Ferguson; A P Gillett; B V Bemand; R A Saunders
Journal:  Diabetologia       Date:  1969-10       Impact factor: 10.122

6.  The effect of the -receptor blockade (propranolol) on the endocrine and exocrine pancreatic function in man after the administration of intestinal hormones (secretion and cholecystokinin-pancreozymin).

Authors:  S Raptis; H Dollinger; M Chrissiku; G Rothenbuchner; E F Pfeiffer
Journal:  Eur J Clin Invest       Date:  1973-05       Impact factor: 4.686

7.  Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.

Authors:  D J Coltart; D G Shand
Journal:  Br Med J       Date:  1970-09-26

8.  The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor.

Authors:  R P Robertson; D Porte
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.